Impact of Helium-Oxygen Administered via High Velocity Nasal Insufflation on Delivery of Inhaled Nitric Oxide
- PMID: 33133741
- PMCID: PMC7588286
- DOI: 10.1055/s-0040-1710057
Impact of Helium-Oxygen Administered via High Velocity Nasal Insufflation on Delivery of Inhaled Nitric Oxide
Abstract
Inhaled nitric oxide (iNO) may be continued during the transition from invasive to noninvasive respiratory support. Upper airway obstruction from laryngeal edema following extubation and lower airway obstruction from asthma and bronchiolitis may be managed with inhaled helium. The coadministration of helium with iNO and the impact on delivered amounts of iNO have not been extensively studied. A bench model simulating a spontaneously breathing infant received iNO at varying preset doses delivered with either helium-oxygen or nitrogen-oxygen via a Vapotherm unit. iNO levels were measured at the simulated trachea. Results from the two conditions were compared using t-tests. When nitrogen-oxygen was used, there was no difference between preset and measured iNO levels. A significant difference was present when helium-oxygen was used, with a 10-fold increase in measured iNO levels compared with preset values. The use of helium resulted in a significant increase in measured iNO at the level of the simulated trachea. Clinicians must be aware that iNO will not be delivered at prescribed doses when used with helium under the conditions used in this study.
Keywords: high flow nasal cannula; high velocity nasal insufflation; inhaled nitric oxide.
Thieme. All rights reserved.
Conflict of interest statement
Conflict of Interest K.B. is associated as a Patient Trainer, Hill-Rom. No conflicts of interest, financial or otherwise, exist for J. H. H., A. S., J. M. B., S. P., and K. M.
Figures
Similar articles
-
Nitric oxide delivery by neonatal noninvasive respiratory support devices.Respir Care. 2015 Feb;60(2):219-30. doi: 10.4187/respcare.03278. Epub 2014 Nov 11. Respir Care. 2015. PMID: 25389351
-
Non-invasive inhaled nitric oxide in the treatment of hypoxemic respiratory failure in term and preterm infants.J Perinatol. 2017 Jan;37(1):54-60. doi: 10.1038/jp.2016.164. Epub 2016 Oct 6. J Perinatol. 2017. PMID: 27711045
-
Inhaled Nitric Oxide via High-Flow Nasal Cannula in Patients with Acute Respiratory Failure Related to COVID-19.Clin Med Insights Circ Respir Pulm Med. 2021 Sep 29;15:11795484211047065. doi: 10.1177/11795484211047065. eCollection 2021. Clin Med Insights Circ Respir Pulm Med. 2021. PMID: 34602831 Free PMC article.
-
Clinical use of inhaled nitric oxide: Local and systemic applications.Free Radic Biol Med. 2020 May 20;152:422-431. doi: 10.1016/j.freeradbiomed.2019.11.029. Epub 2019 Nov 27. Free Radic Biol Med. 2020. PMID: 31785330 Review.
-
The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns?Front Pediatr. 2021 Mar 31;9:631765. doi: 10.3389/fped.2021.631765. eCollection 2021. Front Pediatr. 2021. PMID: 33869113 Free PMC article. Review.
References
-
- Dalton H J. Inhaled nitric oxide: medical miracle or passing fad? Respir Care. 1998;43:978–987.
-
- DiBlasi R M, Dupras D, Kearney C, Costa E, Jr, Griebel J L. Nitric oxide delivery by neonatal noninvasive respiratory support devices. Respir Care. 2015;60(02):219–230. - PubMed
-
- Baudin F, Gagnon S, Crulli B, Proulx F, Jouvet P, Emeriaud G. Modalities and complications associated with the use of high-flow nasal cannula: experience in a pediatric ICU. Respir Care. 2016;61(10):1305–1310. - PubMed
-
- Tremblay J A, Couture E J, Albert M. Noninvasive administration of inhaled nitric oxide and its hemodynamic effects in patients with acute right ventricular dysfunction. J Cardiothorac Vasc Anesth. 2019;33(03):642–647. - PubMed
-
- Tominaga Y, Iwai S, Yamauchi S. Post-extubation inhaled nitric oxide therapy via high-flow nasal cannula after Fontan procedure. Pediatr Cardiol. 2019;40(05):1064–1071. - PubMed
LinkOut - more resources
Full Text Sources